Hematologist
CION Cancer Clinics
The CAR-T wait: what happens while your cells are made | CION Cancer Clinics
Making CAR-T cells usually takes several weeks, and many people receive bridging therapy in that gap. Bridging is a short, gentler treatment, such as steroids, lighter chemotherapy or radiotherapy, that holds the blood cancer steady until the cells come back. Some people with slow disease are simply watched closely instead. This page explains the wait step by step, the warning signs, and what to ask. At CION Cancer Clinics, our haematology team assesses whether a transplant or CAR-T fits your situation and coordinates care with qualified centres.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- What happens while the CAR-T cells are being made?
- What does the wait look like, step by step?
- What kinds of bridging treatment are used?
- What should you do, and what does the team handle?
- What do families often get wrong about the wait?
- What can this page not tell you?
- Common questions about the CAR-T wait and bridging
The short answer
What happens while the CAR-T cells are being made?
Making CAR-T cells usually takes several weeks, and the cancer does not pause while you wait. Many people are given a short, gentler treatment in that gap, called bridging therapy, to hold the disease steady until the cells come back.
Why the wait exists at all
CAR-T is made from your own white cells. After they are collected, they travel to a specialist laboratory. There they are changed so they can find the cancer, grown into a large number, and tested for safety before they are frozen and sent back. Each of those stages takes time, and none of it can be rushed without risking the product.
What bridging therapy is for
Bridging has one job. It keeps the lymphoma, leukaemia or myeloma from growing so fast that you become too unwell to receive the cells. It is not meant to clear the disease on its own. A good bridge is one you come out of with your strength, your kidneys and your blood counts in a state that lets the infusion go ahead.
Not everyone needs one
If the disease is slow and causing few problems, the team may simply watch you closely instead. That is a real decision, not an oversight.
Bridging is chosen by the treating haematologist for your disease. Do not start, stop or change any medicine during the wait without asking them first.The pathway
What does the wait look like, step by step?
-
Cell collection
Your white cells are collected through a drip in a process called apheresis, a machine that separates blood and returns most of it to you. Some treatments are paused beforehand, so the cells collected are as healthy as possible.
-
The cells leave for the laboratory
The bag is packed, labelled and shipped. From this point the clock is running, and the treating centre will tell you the expected return window.
-
Bridging, if you need it
Treatment to hold the disease starts soon after collection. You have regular blood tests and check-ups so the team can see whether it is working and whether you are coping.
-
A scan before the infusion
Many centres repeat a scan or bone marrow test near the end of the wait. It records where the disease stands just before the cells go in.
-
A gap after bridging
Bridging is stopped some days before the next step, so its effects settle. The exact gap depends on the drug used.
-
Conditioning, then the cells
A short course of chemotherapy clears space for the CAR-T cells, and the infusion follows a few days later. Your caregiver needs to be ready from this point.
Not sure whether this applies to you?
Ask an oncologistBridging options
What kinds of bridging treatment are used?
The choice depends on the type of blood cancer, what has already been tried, and where the disease is causing trouble.
Steroids
Often used for a quick, short effect, especially when the disease is causing swelling or pressure. They are simple to give but can raise blood sugar and disturb sleep.
Chemotherapy
A lighter course than the full treatments you may have had before. It is chosen to control the disease without leaving the counts too low when the cells return.
The team weighs
- How you coped with earlier courses
- Your kidney and liver tests
- Your risk of infection
Radiotherapy
Useful when one or two areas of lymphoma are large or causing pain. It treats the spot without lowering the blood counts as much as chemotherapy can.
Targeted drugs
Tablets or injections aimed at a feature of the cancer cell. In myeloma and some leukaemias these may already be part of your plan, and the team decides whether to continue them.
Some drugs affect CAR-T cells, so they are stopped well before collection or infusion.
!
One thing that cannot wait
Bridging can lower your white cell count. If you get a fever, start shivering, become confused, or feel suddenly much worse during the wait, go to the nearest emergency department the same day or call 108. Tell them you are waiting for CAR-T and are on bridging treatment, and call your treating team too. Do not wait for the next clinic visit.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
During the wait
What should you do, and what does the team handle?
Your part
The treating team's part
Keep every blood test and clinic appointment
Decide if bridging is working or needs changing
Report new pain, lumps, fever or breathlessness early
Arrange scans and treat problems before they grow
Eat, rest and walk a little each day to stay strong
Check you are fit enough for conditioning
Plan travel, stay and a caregiver near the centre
Confirm the date the cells will arrive
Ask before taking any new medicine or supplement
Check nothing will harm the cells
Commonly believed
What do families often get wrong about the wait?
"Once the cells are collected, the hard part is over."
The weeks of the wait can be some of the most demanding. The disease is still active, bridging has its own side effects, and you need to stay well enough for the infusion. Plan for this stretch as seriously as the treatment itself.
"If bridging does not shrink the cancer, CAR-T will not work."
Bridging only has to hold things steady. People whose disease did not respond much to bridging may still go on to receive the cells. Your haematologist will explain what the pre-infusion scan means for you.
"Herbal remedies will keep him strong until the cells come back."
Some herbal and home remedies interfere with chemotherapy, affect the liver or raise the risk of bleeding. Show the team everything you plan to take, including ayurvedic and homeopathic products, before you start it.
"No bridging means the team is not doing anything."
Watching closely is a deliberate choice when the disease is slow. It spares you side effects and keeps your counts healthier for the infusion. The blood tests and visits continue either way.
Being straight with you
What can this page not tell you?
This page cannot tell you how long your own cells will take, which bridging treatment suits you, or how your disease will respond. Those depend on the product, the laboratory, your type of blood cancer and everything you have been through before.
Who bridging may not suit
Bridging chemotherapy may not suit someone whose counts are already very low, whose kidneys are struggling, or who has an active infection. In those cases the team may choose radiotherapy, steroids alone, or close watching. If the disease grows very fast despite bridging, the plan may change altogether, and CAR-T may no longer be the right next step.
How CION can help
CION does not make CAR-T cells or give the infusion. Our haematology team, led by Dr. Basudev Pokhrel, reviews your reports, presents your case at a tumour board, a meeting of specialists who plan care together, and helps coordinate with a qualified CAR-T centre. We can also help you understand the bridging plan you have been given.
Questions to take to your treating centre
Ask how long they expect the cells to take, what bridging they suggest and why, which symptoms mean you should call them at once, and what happens if the cells are delayed.
Questions we are asked
Common questions about the CAR-T wait and bridging
How long does it take to make CAR-T cells?
Usually several weeks from collection to the cells being ready, though it varies by product and laboratory. Shipping, quality testing and scheduling all add time. Your treating centre will give you an expected window, and will tell you if it changes. Plan your family's time off and travel around that window rather than one fixed date.
Can I stay at home during the wait?
Often yes, if your bridging treatment can be given as a day-care visit and you live close enough to reach the centre quickly. Families travelling from a district in Telangana or Andhra Pradesh may be asked to stay nearer the centre, especially once bridging lowers the counts. Ask the team what distance they are comfortable with.
Will bridging make me too weak for CAR-T?
That is exactly what the team tries to avoid. Bridging is usually lighter than earlier treatments, and your counts, kidneys and general strength are checked often. If a treatment is wearing you down, they can change it. Tell them honestly how you are managing at home, including eating and walking.
What if the cancer grows while we wait?
The team will review the plan. They may change the bridging treatment, add radiotherapy to a troublesome area, or look again at whether CAR-T is still the right next step. Report new lumps, pain, night sweats or breathlessness as soon as you notice them, so there is time to act.
Can I keep taking my regular medicines?
Some, yes, but only your treating team can say which. A few medicines, including some steroids and blood cancer drugs, can affect collection or the CAR-T cells, and are stopped at set times. Do not stop or change anything yourself. Bring a full list, including supplements, to your next visit.
What if the cells are delayed or cannot be made?
Delays happen, and bridging may simply continue until the cells arrive. Occasionally the laboratory cannot make a product that passes its checks. The team then discusses options such as a second collection, a different treatment or a clinical trial. Ask early how they would handle a delay.
Is bridging covered by insurance or government schemes?
Bridging is usually billed as ordinary chemotherapy, radiotherapy or medicine, so it may be covered under your policy or a scheme such as Aarogyasri, PM-JAY, CGHS, ECHS or EHS. Coverage for CAR-T itself differs. Scheme rules change, so check your current cover with the insurer or scheme desk before you begin.
How can family members help during this time?
Keep a notebook of symptoms, temperatures and questions. Help with travel to appointments and with meals. Know where the nearest emergency department is. Most CAR-T centres also need a named caregiver for the weeks after infusion, so use the wait to decide who that will be.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Accreditation and empanelment
- NABH
- NABL
- ISO 9001:2015
- ArogyaSri empanelled
- CGHS accepted
- ECHS accepted
- EHS accepted
- Major cashless insurers
Paying for it
Insurance, schemes and payment
What you actually pay usually differs a great deal from the sticker figure.
AarogyasriEmpanelled. Bring the card and a referral where you have one.
CGHS / ECHS / EHSAccepted at CION centres for eligible treatment.
Cashless insuranceMost major insurers are empanelled. Pre-authorisation is handled by our desk.
Self-payItemised estimate given before treatment starts. No EMI scheme exists.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. A haematology consultation can be booked at any of these centres through one helpline, and your team will tell you where each test or treatment takes place.
Warangal
Vizag
Sources
- National Cancer Institute — CAR T Cells: Engineering Patients' Immune Cells to Treat Their Cancers
- Cancer Research UK — CAR T-cell therapy
- Leukemia & Lymphoma Society — Chimeric Antigen Receptor (CAR) T-Cell Therapy
- American Cancer Society — CAR T-cell Therapy and Its Side Effects
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Apheresis for CAR-T: The Cell Collection DayThe step that starts the manufacturing clockWhen CAR-T Manufacturing FailsWhat happens if the cells cannot be madeCaregiver Requirements During CAR-TWho needs to be with you once the cells arriveCAR-T: The GapsEvery stage of CAR-T, from referral to follow-up
Talk to us
Waiting for CAR-T and unsure about the plan?
Share your reports with us. CION's haematology team will review them, discuss your case at a tumour board and help you coordinate with a qualified CAR-T centre.